-
Scientists urge vigilance against Omicron subvariants
Apr 21, 2022
Scientists stressed the need to inoculate the vulnerable while urging vigilance against the newly discovered Omicron subvariants, and called for more research to understand their quick transmissibility and severity.
-
Modified guidelines to treat virus outlined
Mar 17, 2022
Modifications to China's COVID-19 diagnosis and treatment guidelines are aimed at relieving strains on the medical system in the face of the highly contagious Omicron variant.
-
FAQs on China's COVID sequential booster immunization
Feb 22, 2022
Fully vaccinated people in China can now choose to receive a different shot from their original inoculation as a booster in a process called sequential immunization.
-
Jiaxing-made automatic nucleic acid testing and analysis system to hit market
Feb 9, 2022
The automatic nucleic acid testing and analysis system developed by Jiaxing-based Accunome Biotechnology Co Ltd recently received approval for marketing.
-
Jiaxing encourages staying put for Spring Festival
Jan 17, 2022
Jiaxing in East China's Zhejiang province issued a notice on Jan 16 to encourage local residents to stay put for the upcoming Spring Festival holiday to help contain the COVID-19 pandemic.
-
New antibody drug to boost COVID fight
Dec 24, 2021
Nearly two years after the COVID-19 outbreak, China has granted emergency approval for its first antibody combination therapy for COVID-19 treatment, adding a tool to the world's arsenal against the disease.
-
What we know about the Omicron variant so far
Dec 1, 2021
Answers to commonly-asked questions about the Omicron variant of COVID-19.
-
Hospitals providing 24-hour nucleic acid tests in Jiaxing
Nov 17, 2021
To better prevent and control the COVID-19 pandemic, nine hospitals in Jiaxing, East China's Zhejiang province are offering 24-hour nucleic acid tests.
17808
Services
- http://subsites.chinadaily.com.cn/ezhejiang/jiaxing/img/attachement/jpg/site48/20191128/1574929579707.jpg
Home> Healthcare